United Therapeutics (UTHR) Other Non-Current Assets (2009 - 2026)

United Therapeutics (UTHR) has 18 years of Other Non-Current Assets data on file, last reported at $233.2 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Assets rose 4.86% year-over-year to $233.2 million; the trailing twelve-month figure through Mar 2026 stood at $233.2 million (up 4.86% YoY), and the FY2025 full-year result was $196.9 million, down 11.35% from the prior year.
• Other Non-Current Assets grew to $233.2 million in Q1 2026, from $196.9 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $262.6 million in Q3 2025 to a low of $105.8 million in Q2 2022.
• A 5-year average of $170.2 million and a median of $167.9 million in 2024 frame the typical range for Other Non-Current Assets.
• Across the five-year window, Other Non-Current Assets slumped 40.23% in 2022 and surged 46.31% in 2024, its largest moves.
• Tracing UTHR's Other Non-Current Assets over 5 years: stood at $114.3 million in 2022, then surged by 32.81% to $151.8 million in 2023, then surged by 46.31% to $222.1 million in 2024, then declined by 11.35% to $196.9 million in 2025, then grew by 18.44% to $233.2 million in 2026.
• Business Quant data shows UTHR's Other Non-Current Assets at $233.2 million in Q1 2026, $196.9 million in Q4 2025, and $262.6 million in Q3 2025.